Anti-Gal antibody-mediated skin graft rejection requires a threshold level of Gal expression

Xenotransplantation

Volumn 15, Issue 1, 2008, Pages 20-26

  Murray Segal, Lisa ^a   Gock, Hilton ^a   Cowan, Peter J ^a   D'Apice, Anthony J F ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

Author keywords

Anti Gal antibody; Gal; Skin graft; Xenotransplantation

Indexed keywords

ALPHA 1,3 GALACTOSYLTRANSFERASE; FUCOSYLTRANSFERASE; GALACTOSE ANTIBODY; GALACTOSYLGALACTOSE; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPLEMENT FIXATION; CONTROLLED STUDY; FLOW CYTOMETRY; GRAFT VERSUS HOST REACTION; HISTOLOGY; IMMUNOHISTOCHEMISTRY; LEUKOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN GRAFT; XENOGRAFT;

EID: 40549107135     PISSN: 0908665X     EISSN: 13993089     Source Type: Journal    
DOI: 10.1111/j.1399-3089.2007.00437.x     Document Type: Article

References (24)

1. 1 Lai L, Kolber‐Simonds D, Park KW et al. Production of alpha‐1,3‐galactosyltransferase knockout pigs by nuclear transfer cloning. Science 2002 ; 295: 1089–1092.
2. 2 Phelps CJ, Koike C, Vaught TD et al. Production of alpha 1,3‐galactosyltransferase‐deficient pigs. Science 2003 ; 299: 411–414.
3. 3 Harrison S, Boquest A, Grupen C et al. An efficient method for producing alpha(1,3)‐galactosyltransferase gene knockout pigs. Cloning Stem Cells 2004 ; 6: 327–331.
4. 4 Yamada K, Yazawa K, Shimizu A et al. Marked prolongation of porcine renal xenograft survival in baboons through the use of a 1,3‐galactosyltransferase gene‐knockout donors and the cotransplantation of vascularized thymic tissue. Nat Med 2005 ; 11: 32–34.
5. 5 Sharma A, Naziruddin B, Cui C et al. Pig cells that lack the gene for alpha1‐3 galactosyltransferase express low levels of the Gal antigen. Transplantation 2003 ; 75: 430–436.
6. 6 Milland J, Christiansen D, Lazarus BD, Taylor SG, Xing PX, Sandrin MS. The molecular basis for Galalpha(1,3)Gal expression in animals with a deletion of the alpha1,3galactosyltransferase gene. J Immunol 2006 ; 176: 2448–2454.
7. 7 Milland J, Christiansen D, Sandrin MS. Alpha1,3‐galactosyltransferase knockout pigs are available for xenotransplantation: are glycosyltransferases still relevant? Immunol Cell Biol 2005 ; 83: 687–693.
8. 8 Gock H, Murray‐Segal L, Salvaris E, Cowan PJ, D’Apice AJ. Gal mismatch alone causes skin graft rejection in mice. Transplantation 2002 ; 74: 637–645.
9. 9 Chen CG, Salvaris EJ, Romanella M et al. Transgenic expression of human alpha1,2‐fucosyltransferase (H‐transferase) prolongs mouse heart survival in an ex vivo model of xenograft rejection. Transplantation 1998 ; 65: 832–837.
10. 10 Tearle RG, Tange MJ, Zannettino ZL et al. The alpha‐1,3‐galactosyltransferase knockout mouse. Implications for xenotransplantation. Transplantation 1996 ; 61: 13–19.
11. 11 Brown SJ, Miller AM, Cowan PJ et al. Altered immune system glycosylation causes colitis in alpha1,2‐fucosyltransferase transgenic mice. Inflamm Bowel Dis 2004 ; 10: 546–556.
12. 12 Chen CG, Fisicaro N, Shinkel TA et al. Reduction in Gal‐alpha 1,3‐Gal epitope expression in transgenic mice expressing human H‐transferase. Xenotransplantation 1996 ; 3: 69–75.
13. 13 Xu H, Sharma A, Chen L et al. The structure of anti‐Gal immunoglobulin genes in naive and stimulated Gal knockout mice. Transplantation 2001 ; 72: 1817–1825.
14. 14 Yin D, Zeng H, Ma L et al. Cutting edge: NK cells mediate IgG1‐dependent hyperacute rejection of xenografts. J Immunol 2004 ; 172: 7235–7238.
15. 15 Zhong R. Gal knockout and beyond. Am J Transplant 2007 ; 7: 5–11.
16. 16 Parker W, Holzknecht ZE, Song A et al. Fate of antigen in xenotransplantation: implications for acute vascular rejection and accommodation. Am J Pathol 1998 ; 152: 829–839.
17. 17 Dorling A, Stocker C, Tsao T, Haskard DO, Lechler RI. In vitro accommodation of immortalized porcine endothelial cells: resistance to complement mediated lysis and down‐regulation of VCAM expression induced by low concentrations of polyclonal human IgG antipig antibodies. Transplantation 1996 ; 62: 1127–1136.
18. 18 Dorling A, Delikouras A, Nohadani M, Polak J, Lechler RI. In vitro accommodation of porcine endothelial cells by low dose human anti‐pig antibody: reduced binding of human lymphocytes by accommodated cells associated with increased nitric oxide production. Xenotransplantation 1998 ; 5: 84–92.
19. 19 Dwyer KM, Robson SC, Nandurkar HH et al. Thromboregulatory manifestations in human CD39 transgenic mice and the implications for thrombotic disease and transplantation. J Clin Invest 2004 ; 113: 1440–1446.
20. 20 Xu H, Yin D, Naziruddin B et al. The in vitro and in vivo effects of anti‐galactose antibodies on endothelial cell activation and xenograft rejection. J Immunol 2003 ; 170: 1531–1539.
21. 21 Ogawa H, Mohiuddin MM, Yin DP, Shen J, Chong AS, Galili U. Mouse‐heart grafts expressing an incompatible carbohydrate antigen. II. Transition from accommodation to tolerance. Transplantation 2004 ; 77: 366–373.
22. 22 Miyatake T, Sato K, Takigami K et al. Complement‐fixing elicited antibodies are a major component in the pathogenesis of xenograft rejection. J Immunol 1998 ; 160: 4114–4123.
23. 23 Dorling A. Are anti‐endothelial cell antibodies a pre‐requisite for the acute vascular rejection of xenografts? Xenotransplantation 2003 ; 10: 16–23.
24. 24 Williams JM, Holzknecht ZE, Plummer TB, Lin SS, Brunn GJ, Platt JL. Acute vascular rejection and accommodation: divergent outcomes of the humoral response to organ transplantation. Transplantation 2004 ; 78: 1471–1478.